This site is for US residents only
- ALPELISIB
- Signature Program
- Signature HCP
- Signature Patient
Breast Cancer
Thoracic Cancer
All compounds are either investigational or being studied for new uses. Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the uses under investigation.
You are now leaving this clinical study website and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site.
If you do not wish to leave this site, click Cancel. Or click OK to continue.